ARCHIVES

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 13 | March 28, 1986

Download PDF Visit The Full Archive

Related Articles

Hybridoma Cell Lines Available from NCI

September 3, 1982

An Unlucky Streak? Doctors Analyze Errors As Another Cancer Center Offers Apology

June 30, 1995

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992

ASCO Members asked To Help In Planning

August 26, 1988